ZIVO Bioscience Stock Forecast for 2023 - 2025 - 2030
Updated on 05/18/2024
ZIVO Bioscience Stock Forecast and Price Target
Based on the current earnings figures, this year's price targets for ZIVO Bioscience were recently set by distinguished experts, with an average mark of $12.00. If it reached this goal, it would represent a potential upside of approximately 50.38% from the previous closing price in May, 2024. The high end is $12.00, and the low is $12.00. Even if you are not interested in ZIVO stock, you should still be aware of its competitors.
50.38% Upside
ZIVO Bioscience Fair Value Forecast for 2023 - 2025 - 2030
ZIVO Bioscience's Price has grown In the last zero years, rising from $0.00 to $0.00 – a growth of 100.00%. In the next year, analysts believe that Fair Value will reach $8.53 – an increase of 100.00%. For the next seven years, experts predict that ZIVO Bioscience's Fair Value will grow at a rate of 100.00%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| LLY Stock Forecast | Eli Lilly and | Outperform |
16
|
$770.00 | Buy/Sell | $636.99 | 13.96% |
| JNJ Stock Forecast | Johnson & Johnson | Outperform |
9
|
$154.64 | Buy/Sell | $174.55 | 9.93% |
| MRK Stock Forecast | Merck | Outperform |
2
|
$131.19 | Buy/Sell | $130.51 | 9.00% |
| PFE Stock Forecast | Pfizer | Outperform |
2
|
$28.64 | Buy/Sell | $32.87 | 6.49% |
| VRTX Stock Forecast | Vertex Pharmaceuticals Inc | Outperform |
12
|
$445.21 | Buy/Sell | $457.59 | 2.70% |
ZIVO Bioscience Revenue Forecast for 2023 - 2025 - 2030
ZIVO Bioscience's Revenue has grown In the last year, rising from $20.00k to $30.00k – a growth of 50.00%. In the following year, 0 experts forecast ZIVO Bioscience's Revenue will decrease by 33.33%, to $20.00k. In 2030, professionals predict that ZIVO Bioscience's Revenue will decrease by 18.16%, to $24.55k.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| REGN Stock Forecast | Regeneron Pharmaceuticals | Outperform |
2
|
$982.29 | Buy/Sell | $961.26 | 6.89% |
| BMY Stock Forecast | Bristol-Myers Squibb | Hold |
2
|
$44.03 | Buy/Sell | $58.15 | 22.64% |
| ZTS Stock Forecast | Zoetis | Outperform |
18
|
$174.06 | Buy/Sell | $220.47 | 26.39% |
.jpg)
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| ALNY Stock Forecast | Alnylam Pharmaceuticals Inc | Outperform |
7
|
$149.40 | Buy/Sell | $245.24 | 45.58% |
| BAX Stock Forecast | Baxter International Inc | Hold |
17
|
$35.25 | Buy/Sell | $44.86 | 24.82% |
| VTRS Stock Forecast | Viatris Inc | Hold |
8
|
$10.98 | Buy/Sell | $11.73 | 9.29% |
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| UTHR Stock Forecast | United Therapeutics | Outperform |
12
|
$274.26 | Buy/Sell | $284.08 | 9.39% |
| CTLT Stock Forecast | Catalent | Hold |
15
|
$55.37 | Buy/Sell | $49.29 | 14.68% |
| CYTK Stock Forecast | Cytokinetics | Outperform |
10
|
$59.53 | Buy/Sell | $87.92 | 57.90% |
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| IONS Stock Forecast | Ionis Pharmaceuticals | Outperform |
9
|
$37.31 | Buy/Sell | $55.60 | 60.81% |
| BCPC Stock Forecast | Balchem | Outperform |
18
|
$155.83 | Buy/Sell | $145.00 | 5.88% |
| MDGL Stock Forecast | Madrigal Pharmaceuticals | Outperform |
4
|
$220.06 | Buy/Sell | $315.92 | 75.41% |
ZIVO Bioscience EBIT Forecast for 2023 - 2025 - 2030
In the last three years, ZIVO Bioscience's EBIT has decreased from $-8.56M to $-7.26M – a 15.19% drop. In the following year, 1 experts forecast that ZIVO Bioscience's EBIT will decrease by 8.54%, to $-6.64M. Over the next seven years, experts predict that ZIVO Bioscience's EBIT will grow at a rate of 1.07%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| PRGO Stock Forecast | Perrigo Co PLC | Outperform |
16
|
$29.83 | Buy/Sell | $44.75 | 34.09% |
| NEOG Stock Forecast | Neogen | Outperform |
16
|
$13.54 | Buy/Sell | $37.00 | 25.55% |
| CORT Stock Forecast | Corcept Therapeutics | Buy |
16
|
$28.09 | Buy/Sell | $35.67 | 42.40% |
ZIVO Bioscience EPS Price Prediction Forecast for 2023 - 2025 - 2030
ZIVO Bioscience's EPS has grown In the last zero years, rising from $0.00 to $0.00 – a growth of 100.00%. In the next year, analysts believe that EPS will reach $-2.03 – an increase of 100.00%. For the next seven years, experts predict that ZIVO Bioscience's EPS will grow at a rate of 100.00%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| INDV Stock Forecast | Indivior PLC | Buy |
14
|
£13.37 | Buy/Sell | £28.89 | 131.34% |
| TGTX Stock Forecast | TG Therapeutics | Outperform |
9
|
$16.48 | Buy/Sell | $29.44 | 109.34% |
| AMPH Stock Forecast | Amphastar Pharmaceuticals | Outperform |
14
|
$43.48 | Buy/Sell | $69.00 | 42.59% |
.jpg)